PROSPECTS AND OPPORTUNITIES
Stable growth expected, with topical formats driving resilience
Value sales of analgesics are expected to rise modestly over the forecast period overall. Growth will depend largely on the stability of supply chains and access to raw materials, as any renewed disruption could trigger short-term fluctuations similar to those seen in recent years.
Digitalisation and online distribution to expand consumer access
E-commerce will continue to reshape the analgesics landscape as Czech consumers increasingly turn to digital platforms for convenient access to OTC medicines. Online pharmacies are expected to invest in broader product ranges, loyalty programmes and same-day delivery, boosting their competitiveness against traditional retail channels.
New opportunities from regulatory change and alternative pain management
Legislative developments will also shape the market outlook. From April 2025, general practitioners in the Czech Republic are authorised to prescribe medical cannabis for chronic pain, opening an alternative to conventional analgesics for certain patient groups.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Czech Republic with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Czech Republic, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Czech Republic report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Czech Republic?
- Which are the leading brands in Analgesics in Czech Republic?
- How are products distributed in Analgesics in Czech Republic?
- How has the regulatory and operating environment for Analgesics changed in Czech Republic?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in the Czech Republic - Category analysis
KEY DATA FINDINGS
Supply chain disruptions ease, yet demand remains volatile
Sanofi retains leadership, Haleon strengthens position in topical pain relief
Pharmacies dominate distribution, but online channels expand rapidly
Stable growth expected, with topical formats driving resilience
Digitalisation and online distribution to expand consumer access
New opportunities from regulatory change and alternative pain management
Consumer Health in the Czech Republic - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!